-
Mashup Score: 0A message from our president | EULAR - 10 month(s) ago
A Message from the EULAR President Dear Friends, I am very honoured to address you all in my new role as President of EULAR and extend my warmest greetings to all of you. EULAR has been a beacon of excellence in the field of Rheumatology since its establishment in 1947, earning a distinguished reputation as a non-profit organisation in the service for individuals with…
Source: EULARCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0EULAR | Press Releases - 1 year(s) ago
NEW: REPORTING REQUIREMENTS IN RESEARCH EULAR ‘points to consider’ published in the Annals of the Rheumatic Diseases — Synovial tissue makes up the lining of a joint, and is critical for its function. In order to help standardize data collection in this field, EULAR – the European Alliance of Associations for Rheumatology – propose a set of new points to consider for minimal reporting…
Source: eular.orgCategories: Latest Headlines, RheumatologyTweet-
📰 HOT OFF THE PRESS! "No Impact of Diet in RMD Outcomes" 🌍 #EULAR has published new recommendations regarding lifestyle behaviours and work participation to prevent progression of #RMDs. Read the #eularPressRelease now! 👉 https://t.co/zMVoSO12OJ #Rheumatology #PressRelease https://t.co/JAx1UkeWFg
-
-
Mashup Score: 1EULAR | WAD Campaign - 2 year(s) ago
Learn more / Join our webinar To improve rheumatological care across diverse countries, it is essential that we treat the root cause of the problem: that rheumatology is invisible. Underrepresentation at universities means few medical students choosing this specialisation, while non-specialised audiences do not understand RMD symptoms and thus remain unaware and uninformed about how RMDs…
Source: eular.orgCategories: Latest Headlines, RheumatologyTweet-
📢 Today is World Arthritis Day 2022! What is your #RheumaPainPoint ? 🌍 World Arthritis Day aims to raise awareness about the impact of #RMDs. 💻 Join the campaign and share your thoughts and experiences with us! 👉 https://t.co/vkJEQq7L1w #WAD #AwarenessDay #EULAR https://t.co/erQwBYK5RL
-
-
Mashup Score: 9
Objectives This study investigates whether COVID-19 vaccines can elicit cross-reactive antibody responses against the Omicron variant in patients with autoimmune rheumatic diseases (ARDs). Methods This observational cohort study comprised 149 patients with ARDs and 94 healthcare workers (HCWs). Blood samples were obtained at enrolment, a median of 15 weeks after the second vaccine dose or 8…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet-
#Omicron evades the antibody response in vaccinated people with #RMDs☣️ 👉 only 39.2% of the patient sera showed functional neutralisation capacity to Omicron 👉 more breakthrough infections occur in patients with lower Omicron-neutralising responses https://t.co/6V3WIt8wBp https://t.co/SaXmJnDvcE
-
-
Mashup Score: 0EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases - 2 year(s) ago
Objective To develop EULAR points-to-consider for therapeutic drug monitoring (TDM) of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases (RMDs). Methods The points-to-consider were developed in accordance with EULAR standardised operation procedures by a multidisciplinary task force from eight European countries, based on a systematic literature review and expert…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet-
Do you consider drug monitoring in your patients with #RMDs? @eular_org task force has now published on what to consider for therapeutic #drug monitoring of biopharmaceuticals https://t.co/PJuznWuzb5 #DMARDs #trials #biologic @ProfJohnIsaacs https://t.co/7zSQvObm7k
-
-
Mashup Score: 2EULAR | Recommendations for management - 2 year(s) ago
This page lists the EULAR Recommendations for management dating back to the year 2011. Scroll to the bottom of the page to start the year 2011, scrolling upwards through the years to the present day. Each authors lists the following: The authors, the title, the publication citation, publication date and link to the final, published recommendation text. Annette de Thurah, Philipp Bosch,…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet-
📣 Read the latest #EULARpointstoconsider 📣 🔔 2022 #EULAR Points to Consider for remote care in #rheumatic and #musculoskeletal diseases 🔗 View the publication 👉 https://t.co/xG2LWlQlNi #Rheuma #remotecare #rheumatology #RMDs @EMEUNET @eularHPR @YelizPrior https://t.co/taGgw0z9O8
-
-
Mashup Score: 0
Background A EULAR taskforce was convened to develop recommendations for lifestyle behaviours in rheumatic and musculoskeletal diseases (RMDs). The aim of this paper was to review the literature on the relationship between smoking and alcohol consumption with regard to RMD-specific outcomes. Methods Two systematic reviews were conducted to identify systematic reviews and meta-analyses, published…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet-
Check out the latest findings on the effect of #smoking and #alcohol intake in #RMDs ▶️ smoking linked to poor outcomes in #RA and #axSpA ▶️ alcohol assocaited with radiographic progression in RA and flares in #gout ▶️ limited evidence for other RMD 🔗 https://t.co/RW8f5KX5YE https://t.co/RD5zr32SDF
-
-
Mashup Score: 5EULAR | Recommendations for management - 2 year(s) ago
This page lists the EULAR Recommendations for management dating back to the year 2011. Scroll to the bottom of the page to start the year 2011, scrolling upwards through the years to the present day. Each authors lists the following: The authors, the title, the publication citation, publication date and link to the final, published recommendation text. Robert B M Landewé, Alessia Alunno,…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet-
📣 Read the latest #EULARrecommendations 📣 🔔 Management and #vaccination of people with #RMDs in the context of #SARSCoV2: the November 2021 #update 🔗 View the publication 👉https://t.co/vO2UQAQ1wO @EMEUNET @eularYoungPARE @eularHPR #COVID19 https://t.co/RJ4aO0N9wT
-
-
Mashup Score: 0EULAR | Press Releases - 2 year(s) ago
Updated: Dealing with FAQ around COVID vaccination EULAR has updated its guidance to help answer patients’ questions — COVID-19 vaccines have been shown to be safe and effective in people with rheumatic and musculoskeletal diseases (RMDs), as well as in people receiving drugs…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet-
🆕 Update on the EULAR 2021 View-points on SARS-CoV-2 #vaccination in patients with #RMDs: a guidance to answer patients’ questions 📰 Read the press release 👉 https://t.co/N3rQ0UricR 📄 View points: https://t.co/TCs528Za3b @ARD_BMJ @EMEUNET @eularYoungPARE @eularHPR #COVID https://t.co/NYWk6Gdri3
-
-
Mashup Score: 2EULAR | Press Releases - 2 year(s) ago
New: COVAX results Registry data reveal safety of COVID-19 vaccines in people with rheumatic and musculoskeletal diseases — In general, people with inflammatory or autoimmune rheumatic and musculoskeletal diseases (RMDs) have not been included in the clinical trial programs for…
Source: www.eular.orgCategories: Latest Headlines, RheumatologyTweet-
📰 HOT OFF THE PRESS! #COVAX registry data reveals #safety of #COVID19 #vaccines in people with rheumatic and musculoskeletal diseases Read the #eularPressRelease now! 👉 https://t.co/rJWGH0eCXH #EULARCOVAXRegistry #EULAR #eularRESEARCH #RMDs #vaccination @EMEUNET @PReSEMERGE https://t.co/OKxY3QA6FU
-
🌟 #EULAR is excited to present the new message from our esteemed President, Prof. Daniel Aletaha 🌍 His message encapsulates the passion and dedication that drive us to make a meaningful impact on the lives of people with #RMDs. 👉 https://t.co/f7aSraMprN @DanielAletaha https://t.co/CPJL4eo7F4